 |
|
Non-achievement of the Low-Density Lipoprotein Cholesterol Goal in Older Patients with Type 2 Diabetes Mellitus and a Very High Cardiovascular Disease Risk: A Multicenter Study in Vietnam
Huan Thanh Nguyen, Khang Pham Trong Ha, An Huu Nguyen, Thu Thanh Nguyen, Hang My Lam
Ann Geriatr Med Res. 2021;25(4):278-285. Published online 2021 Dec 6 DOI: https://doi.org/10.4235/agmr.21.0099
|
|
Citations to this article as recorded by
 Re-evaluating the PCSK9 guidelines for low-density lipoprotein cholesterol targets: weighing the benefits against the risks
Terry Gbaa, John Bolodeoku
Cardiovascular Prevention and Pharmacotherapy.2024; 6(3): 85. CrossRef 2024 Egyptian consensus statement on the role of non-statin therapies for LDL cholesterol lowering in different patient risk categories
Hesham Salah El Din Taha, Hossam Kandil, Hala Mahfouz Badran, Nabil Farag, Hazem Khamis, Gamila Nasr, Mina Samy, Moustafa Abdrabou, Mohamed Abuelezz, Mirna Mamdouh Shaker
The Egyptian Heart Journal.2024;[Epub] CrossRef The prevalence of excess weight among Vietnamese adults: A pooled analysis of 58 studies with more 430 thousand participants over the last three decades
Tran Thai Phuc, Tran Quang Duc, Vu Thi Quynh Chi, Phan Ngoc Quang
Nutrition and Health.2023; 29(3): 443. CrossRef The Chinese Metabolic Management Centers
Jianmin Liu, Zachary Bloomgarden
Journal of Diabetes.2022; 14(6): 362. CrossRef
|